Congruence between patient characteristics and interventions may partly explain medication adherence intervention effectiveness: an analysis of 190 randomized controlled trials from a Cochrane systematic review

被引:36
作者
Allemann, Samuel S. [1 ]
Nieuwlaat, Robby [2 ]
Navarro, Tamara [2 ]
Haynes, Brian [2 ]
Hersbergera, Kurt E. [1 ]
Arnet, Isabelle [1 ]
机构
[1] Univ Basel, Dept Pharmaceut Sci, Pharmaceut Care Res Grp, Klingelbergstr 50, CH-4056 Basel, Switzerland
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton Gen Hosp Campus,237 Barton St, East Hamilton, ON L8L 2X2, Canada
关键词
Patient adherence; Meta-analysis; Research methods; Randomized controlled trials; Determinants of non-adherence; Compliance; ENHANCING INTERVENTIONS; COST-EFFECTIVENESS; HEALTH; CARE; NONADHERENCE; HYPERTENSION; PHARMACY; IMPROVES; THERAPY; IMPACT;
D O I
10.1016/j.jclinepi.2017.07.011
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: Due to the negative outcomes of medication nonadherence, interventions to improve adherence have been the focus of countless studies. The congruence between adherence-related patient characteristics and interventions may partly explain the variability of effectiveness in medication adherence studies. In their latest update of a Cochrane review reporting inconsistent effects of adherence interventions, the authors offered access to their database for subanalysis. We aimed to use this database to assess congruence between adherence-related patient characteristics and interventions and its association with intervention effects. Study Design and Setting: We developed a congruence score consisting of six features related to inclusion criteria, patient characteristics at baseline, and intervention design. Two independent raters extracted and scored items from the 190 studies available in the Cochrane database. We correlated overall congruence score and individual features with intervention effects regarding adherence an d clinical outcomes using Kruskal Wallis rank sum test and Fisher's exact test. Results: Interrater reliability for newly extracted data was almost perfect with a Cohen's Kappa of 0.92 [95% confidence interval (CI) = 0.89-0.94; P < 0.001]. Although present in only six studies, the inclusion of nonadherent patients was the single feature significantly associated with effective adherence interventions (P = 0.003). Moreover, effective adherence interventions were significantly associated with improved clinical outcomes (odds ratio = 6.0; 95% CI = 3.1-12.0; P < 0.0001). However, neither the overall congruence score nor any other individual feature (i.e., "determinants of nonadherence as inclusion criteria," "tailoring of interventions to the inclusion criteria," "reasons for nonadherence assessed at baseline," "adjustment of intervention to individual patient needs," and "theory-based interventions") was significantly associated with intervention effects. Conclusion: The presence of only six studies that included nonadherent patients and the interdependency of this feature with the remaining five might preclude a conclusive assessment of congruence between patient characteristics and adherence interventions. In order to obtain clinical benefits from effective adherence interventions, we encourage researchers to focus on the inclusion of nonadherent patients. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:70 / 79
页数:10
相关论文
共 50 条
  • [1] The UK national institute for health and clinical excellence public health guidance on behaviour change: A brief introduction
    Abraham, Charles
    Kelly, Michael P.
    West, Robert
    Michie, Susan
    [J]. PSYCHOLOGY HEALTH & MEDICINE, 2009, 14 (01) : 1 - 8
  • [2] Matching Adherence Interventions to Patient Determinants Using the Theoretical Domains Framework
    Allemann, Samuel S.
    Nieuwlaat, Robby
    van den Bemt, Bart J. f
    Hersberger, Kurt E.
    Arnet, Isabelle
    [J]. FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [3] [Anonymous], 2008, Biostatistics: The Bare Essentials
  • [4] Baudrant-Boga M., 2012, ANNALES PHARMACEUTIQUES FRANCAISES, V70, P15, DOI 10.1016/j.pharma.2011.10.003
  • [5] SOCIOBEHAVIORAL DETERMINANTS OF COMPLIANCE WITH HEALTH AND MEDICAL CARE RECOMMENDATIONS
    BECKER, MH
    MAIMAN, LA
    [J]. MEDICAL CARE, 1975, 13 (01) : 10 - 24
  • [6] Adherence to antiretroviral therapy in HIV-infected pediatric patients improves with home-based intensive nursing intervention
    Berrien, VM
    Salazar, JC
    Reynolds, E
    McKay, K
    [J]. AIDS PATIENT CARE AND STDS, 2004, 18 (06) : 355 - 363
  • [7] Validation of the theoretical domains framework for use in behaviour change and implementation research
    Cane, James
    O'Connor, Denise
    Michie, Susan
    [J]. IMPLEMENTATION SCIENCE, 2012, 7
  • [8] Utilizing an Ingestible Biosensor to Assess Real-Time Medication Adherence
    Chai P.R.
    Castillo-Mancilla J.
    Buffkin E.
    Darling C.
    Rosen R.K.
    Horvath K.J.
    Boudreaux E.D.
    Robbins G.K.
    Hibberd P.L.
    Boyer E.W.
    [J]. Journal of Medical Toxicology, 2015, 11 (4) : 439 - 444
  • [9] Chin R, 2008, PRINCIPLES AND PRACTICE OF CLINICAL TRIAL MEDICINE, P1, DOI 10.1016/B978-0-12-373695-6.00001-6
  • [10] Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-Analysis
    Demonceau, Jenny
    Ruppar, Todd
    Kristanto, Paulus
    Hughes, Dyfrig A.
    Fargher, Emily
    Kardas, Przemyslaw
    De Geest, Sabina
    Dobbels, Fabienne
    Lewek, Pawel
    Urquhart, John
    Vrijens, Bernard
    [J]. DRUGS, 2013, 73 (06) : 545 - 562